Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

NCT04888936 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT04888936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
April 25, 2022
Completion date
January 31, 2035
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

capillary arteriovenous malformation syndrome, cardiofaciocutaneous syndrome, costello syndrome, legius syndrome, noonan syndrome, rasopathy